Director, HV&E, Specialty Care (Medical Dermatology) - Secondment 6 months

WHY PATIENTS NEED YOU 

Our focus is on patients and understanding the critical role our medicines play to produce better health outcomes. As a cross functional team of experts, we create and execute comprehensive value and access strategies through the integration of an evidence plan, health technology assessment, real-world evidence, and health economic modeling activities. Your expertise and innovative approach will enhance the value of our medicines and the impact to patient outcomes. 

WHAT YOU WILL ACHIEVE 

You will be part of Pfizer’s dynamic Global Access and Value (GAV) team and will have the important role of creating and executing the HTA, Value & Evidence (HV&E) strategy. The Director, HV&E secondee will support ritlecitinib (Litfulo), an exciting launch asset in the Medical Dermatology portfolio. You will be responsible for the evidence generation strategy at a Global level, including oversight and development of evidence generation and dissemination of technical deliverables to successful access strategy. This role is focused on generating evidence through incorporation into clinical trial programs and real-world data studies as well as ensuring value and evidence generation around the economic and humanistic aspects. You will participate in specialized projects within the realm of I&I, aiding in crafting and implementing comprehensive access evidence strategies. 

HOW YOU WILL ACHIEVE IT 

• Lead the development of the HTA, Value & Evidence Strategy to support the access values of assets in close partnership with the cross-functional matrix team 

• Work closely with PRD, CMAO, WRD, and commercial to ensure that their access evidence/HEOR needs are met  

• Work with cross-functional teams to ensure an aligned value and evidence plan at the Global level.  

• Develop real world evidence generation strategies and lead the design and execution of studies (e.g., treatment patterns, real world effectiveness, burden of illness studies, epidemiology studies, etc.) to generate evidence to support brand competitive differentiation and value proposition. 

• Lead the execution of clinically relevant and scientifically valid, cutting edge HEOR studies and projects (including non-interventional studies, registries, etc.) in alignment with the global HEOR strategy catered to diverse stakeholders (regulators, payers, patients, physicians and policy makers) 

• Lead the development of appropriate data dissemination plans and communicate in a